Loxapine and Bundle branch block left - a phase IV clinical study of FDA data

Summary:

Bundle branch block left is found among people who take Loxapine, especially for people who are male, 60+ old.

The phase IV clinical study analyzes which people take Loxapine and have Bundle branch block left. It is created by eHealthMe based on reports of 3,628 people who have side effects when taking Loxapine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 06, 2023

3,628 people reported to have side effects when taking Loxapine.
Among them, 9 people (0.25%) have Bundle branch block left.

What is Loxapine?

Loxapine has active ingredients of loxapine succinate. eHealthMe is studying from 3,661 Loxapine users for its effectiveness, alternative drugs and more.

What is Bundle branch block left?

Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle) is found to be associated with 1,358 drugs and 713 conditions by eHealthMe.

Number of Loxapine and Bundle branch block left reports submitted per year:

Could Loxapine cause Bundle branch block left?

Gender of people who have Bundle branch block left when taking Loxapine *:

female: 0.0 %
male: 100 %

Age of people who have Bundle branch block left when taking Loxapine *:

Common drugs people take besides Loxapine *:

Common side effects people have besides Bundle branch block left *:

Sinus Tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node): 9 people, 100.00%
Troponin Increased: 8 people, 88.89%
Electrocardiogram T Wave Abnormal: 8 people, 88.89%
Electrocardiogram Qrs Complex Prolonged: 8 people, 88.89%
Electrocardiogram Abnormal: 8 people, 88.89%
Drug Level Increased: 8 people, 88.89%
Drug Level Above Therapeutic: 7 people, 77.78%
Hospitalisation: 6 people, 66.67%
Electrocardiogram Qt Prolonged: 1 person, 11.11%
Cardiac Arrest: 1 person, 11.11%

Common conditions people have *:

Schizophrenia, Paranoid Type (delusions and auditory hallucinations but relatively normal intellectual functioning and expression of affect): 1 person, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Loxapine and have Bundle branch block left?

Check whether Bundle branch block left is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Li W, Lamichhane J, "From Heartbreak to Left Bundle Branch Block: A Case of Amitriptyline Overdose", American Journal of Therapeutics, 2017 Sep .

Related studies

How severe was Bundle branch block left and when was it recovered:

Bundle branch block left in Loxapine

Expand to all the drugs that have ingredients of loxapine succinate:

Bundle branch block left and drugs with ingredients of loxapine succinate

Alternative drugs to, pros and cons of Loxapine:

Loxapine (3,661 reports)

Common Loxapine side effects:

Browse all side effects of Loxapine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Bundle branch block left treatments and more:

Bundle branch block left (6,051 reports)

COVID vaccines that are related to Bundle branch block left:

Common drugs associated with Bundle branch block left:

How the study uses the data?

The study uses data from the FDA. It is based on loxapine succinate (the active ingredients of Loxapine) and Loxapine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.